Trump Loosens Psychedelic Research Restrictions

0:00It's April 19th. This is California News Today, driven by AI. President Trump just signed an executive order to loosen restrictions on psychedelic research. Zeroing in on eyeball gain for treating post-traumatic, stress disorder and other issues. The signing happened in the Oval Office with Health Secretary Robert F. Kennedy Jr. and podcaster Joe Rogan right there. Trump announced a $50 million federal investment to speed up studies and opened a path under the FDA's right to try rule for desperately. Ill patients to get eyeball gain. Trump stressed this could be huge for veterans facing sky-high suicide rates, calling it life-changing with broad support across the board. FDA Commissioner Marty McCary revealed three psychedelics would join a fast-track priority program to cut review times and human trials for eyeball gain. Our starting soon to tackle unmet needs like addiction. Children comes from an African shrub and shows promise against depression, anxiety and opioids, but as a schedule one drug, it's risky with heart.

1:04Complications linked to deaths and clinics abroad. More big trials are key before it goes mainstream and this move could spark real change for treatments nationwide.